اگر می توانیم آن را شبیه سازی نماییم، آن را بیمه نیز می توانیم کنیم : درخواست برای مدیریت ریسک طول عمر
|کد مقاله||سال انتشار||تعداد صفحات مقاله انگلیسی||ترجمه فارسی|
|803||2013||11 صفحه PDF||سفارش دهید|
نسخه انگلیسی مقاله همین الان قابل دانلود است.
هزینه ترجمه مقاله بر اساس تعداد کلمات مقاله انگلیسی محاسبه می شود.
این مقاله تقریباً شامل 11710 کلمه می باشد.
هزینه ترجمه مقاله توسط مترجمان با تجربه، طبق جدول زیر محاسبه می شود:
- تولید محتوا با مقالات ISI برای سایت یا وبلاگ شما
- تولید محتوا با مقالات ISI برای کتاب شما
- تولید محتوا با مقالات ISI برای نشریه یا رسانه شما
پیشنهاد می کنیم کیفیت محتوای سایت خود را با استفاده از منابع علمی، افزایش دهید.
Publisher : Elsevier - Science Direct (الزویر - ساینس دایرکت)
Journal : Insurance: Mathematics and Economics, Volume 52, Issue 1, January 2013, Pages 35–45
This paper proposes a unified framework for measuring and managing longevity risk. Specifically, we develop a flexible framework for valuing survivor derivatives like forwards, and swaps, as well as options both of European and American style. Our framework is essentially independent of the assumed underlying dynamics and the choice of method for risk neutralization and relies only on the ability to simulate from the risk neutral process. We provide an application to derivatives on the survivor index when the underlying dynamics are from a Lee–Carter model. Our results show that taking the optionality into consideration is important from a pricing perspective.
In 1986 the rock band Queen sang “Who wants to live forever?” in which they conclude “Who waits forever anyway?” They could have easily put in song “Who wants to live old and poor forever?” for that is the risk of outliving our assets. Indeed, outliving our assets is not an enviable outcome of increased longevity at older ages, and anyone would probably try to avoid running out of funds when they are old and grey. Sadly, however, lacking financial resources is one of the pernicious effects stemming from the risk of a population living longer than planned, so that not enough money has been saved to fulfill its financial needs. We refer to this risk as longevity risk. Put differently, longevity risk arises when the annuitants’ actual life expectancy is greater than their expected life expectancy. Unknown longevity affects the overall profitability of institutions that offer lifetime pensions, such as large corporations and governments, as well as the total savings of individuals. Financially, aggregate longevity risk is mostly negative since retirement systems in developed countries rely on aggregate mortality rate forecasts to calculate an individual’s pension benefits until his death (not to mention all other costs associated with old-age, such as medicare and disability benefits). When the life expectancy of a cohort of pensioners exceeds forecasts, the retirement system must pay this cohort income that exceeds the level initially projected and accumulated. It is then exposed to the risk of lacking the capital needed to meet its financial commitments. The problem is similar for individuals who are accumulating wealth in expectation of converting all that wealth into annuities upon retirement (see Levhari and Mirman, 1977, and Davies, 1981); an unanticipated increase in longevity will lead to insufficient wealth accumulation on the part of an individual who will then need to either reduce consumption more than anticipated or delay retirement altogether (see Cocco and Gomes, 2012).1 Considering the size of the risk exposure, the only way to potentially manage longevity risk is, arguably, by drawing upon the wealth of the entire capital market. The argument is essentially that even though potential losses due to longevity risk are larger than what any one insurer or group of insurers can assume, such a loss exposure is not uncommon for the capital markets. Put differently, what is a systemic risk for the life insurance market is an idiosyncratic risk for the entire capital market. The ability of capital markets to absorb larger amounts of risk than the market for life reinsurance stems from two factors. First, capital markets are very large and much larger than the market capitalization and surplus of the insurance industry, and second, there is virtually no correlation between longevity risk and market risk so that exposure to longevity risk shifts the portfolio frontier up and to the left. The benefit to capital market participants of assuming this type of risk is that it gives money managers access to a new class of assets. Because of the negligible correlation between longevity risk assets and the money managers’ portfolio of financial assets, having exposure to longevity risk can decrease the volatility of their entire book of business. Capital markets have started to develop products that allow financial institutions to invest in mortality and longevity. The primary example of such a product is the mortality swap whereby one party will pay a measure of expected mortality and in return will receive a measure of actual mortality experience (for a discussion of other types of longevity derivatives see Blake et al., 2006, inter alia). One of the reasons why capital markets have been relatively slow in developing longevity products is that calculating their fair value raises many challenges. First of all, mortality, unlike financial assets, is not a traded asset and therefore longevity products cannot be valued simply by the absence of arbitrage (under the risk-neutral measure) since no replication portfolio can be built. It is therefore necessary to use incomplete market valuation methods that imply the existence of a market risk premium, which can only be appraised using market data. Secondly, given that the cash flows of these products are directly linked to mortality or survival rates their valuation requires the ability to forecast these rates accurately. While this could be achieved using mortality projection models, these are oftentimes somewhat non-standard, at least from a derivatives pricing perspective. The goal of this paper is to develop a flexible framework for pricing essentially all types of longevity derivatives which is independent of the assumed dynamics. For this reason we choose to use simulation techniques. Simulation techniques are widely used in the finance literature to price derivatives. We show how this framework can be used to price survivor forwards, swaps, and both European and American style options. Though it is possible to obtain closed-form, and hence simpler, formulas for some longevity forwards and swaps, and for some European options, such closed-form solutions generally require restrictive assumptions about the dynamics of the underlying risk factors. For example, Dawson et al. (2010) rely on a tightly parameterized beta distribution to derive their closed-form Black–Scholes–Merton-type prices for the European swaption. Compared to this our framework is much more flexible and all that is needed is the ability to simulate from the risk neutral distribution, something that is often the case after an appropriate distortion or transformation. Moreover, even if the choice of model allows for closed-form solutions for some types of derivative contracts, this will not be the case for derivatives that allow, e.g., early exercise (such as the American option) or whose value is path dependent (such as up-and-in and down-and-out options, or Asian options). Thus, in order to price these instruments numerical methods have to be used. One important advantage of the simulation method is that it can easily be augmented to take path dependence into consideration. It can also be extended to incorporate possible early exercise. Finally, it should be noted that simulation methods are particularly well suited to price derivatives on multiple underlying risks. In particular, the computational complexity of the simulation technique grows linearly in the number of risks, whereas most other numerical methods that exist for option pricing are plagued with a computational complexity that grows exponentially in the number of risks—and hence are said to suffer from the “curse of dimensionality”. The simulation framework we propose in the current paper is flexible enough to accommodate the particular features of the insurance mortality data. As an application, we show how it can be applied to manage longevity risk where the mortality distribution follows a Lee–Carter model, though any other model could be used (see Robine, 2011, and Gaille, 2010, for surveys of mortality models used in the current context).2 To be specific, we price survivor forwards, swaps, and options in this unified framework. Our results show that taking the optionality into consideration is important from a pricing perspective and if this is neglected the value of these products is severely underestimated. Since insurance and reinsurance contracts can be seen as put options, this finding has non-trivial implications for the valuation of such contracts. In fact, the inherent flexibility of the simulation method we propose allows one to price efficiently various types of derivatives (such as bull and bear spreads, knock-in and lookback options, etc.) which, in turn, allows one to design and price products that enable insurers and reinsurers to manage risk exposure efficiently. Thus, a framework as flexible as the one we propose has extraordinary applications for the management of risk in the context of longevity risk. The rest of this paper proceeds as follows. In Section 2 we provide a review of some of the products that have been proposed in the market for longevity risk. We also suggest a new product: a survivor option with time varying strike prices. In Section 3 we explain how these products can be priced using simulation techniques. In Section 4 we provide an application of our framework to a simple model and provide prices for the various products. Finally, Section 5 concludes.
نتیجه گیری انگلیسی
This paper develops a unified framework for measuring and managing the risk of insurance products. Specifically, we propose to use a flexible simulation based approach that has been used successfully in pricing financial derivatives. Based on this least squares Monte-Carlo approach, derivative products such as reinsurance contracts that can be seen as put options can be designed to enable the insurer to value and manage its risk exposure efficiently. Because of its flexibility, the simulation approach is particularly well suited to be used for pricing derivative products on longevity risk since modeling the underlying risk factors is non-standard. All that is required is the ability to simulate from the risk neutral distribution. This can often be obtained through distortion or other equivalent transformations. The simulation method can be used to price derivatives with path dependence as well as derivatives that allow, e.g., early exercise such as the American style options. We show how this technique can be applied to manage longevity risk when the mortality distribution follows a Lee–Carter model. Our results show that taking the optionality into consideration is important from a pricing perspective. Moreover, the possibility of exercising the options early increases the value of put options significantly. Our findings have important implications for the valuation of reinsurance contracts that are essentially put options. We also price products in a high interest rate scenario and for cohorts of different ages. The results show that the premium of forward contracts, swaps, and options decrease marginally with the interest rate but increase significantly with cohort age. Though the application we provide is to a very simple benchmark Lee–Carter model, the simulation method we propose can be used to price longevity products in general irrespective of the assumed model. An obvious extension is to apply our methodology to more complicated models. This can be done with little or no complications as long as it remains possible to simulate directly from the driving risk neutral distribution. Our approach can also easily incorporate parameter uncertainty by applying simple Bayesian methods, and it would be interesting to examine the effect of this particularly on the older cohorts. Finally, other extensions include pricing longer maturity contracts and contracts on other survivor indices.